443 related articles for article (PubMed ID: 33913810)
1. TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.
Merritt N; Garcia K; Rajendran D; Lin ZY; Zhang X; Mitchell KA; Borcherding N; Fullenkamp C; Chimenti MS; Gingras AC; Harvey KF; Tanas MR
Elife; 2021 Apr; 10():. PubMed ID: 33913810
[TBL] [Abstract][Full Text] [Related]
2. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
3.
Seavey CN; Pobbati AV; Hallett A; Ma S; Reynolds JP; Kanai R; Lamar JM; Rubin BP
Genes Dev; 2021 Apr; 35(7-8):512-527. PubMed ID: 33766982
[TBL] [Abstract][Full Text] [Related]
4. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
[TBL] [Abstract][Full Text] [Related]
6. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement.
Thway K; Mentzel T; Perrett CM; Calonje E
Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.
Lamar JM; Motilal Nehru V; Weinberg G
Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478
[TBL] [Abstract][Full Text] [Related]
8. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
Lee SJ; Yang WI; Chung WS; Kim SK
Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
[TBL] [Abstract][Full Text] [Related]
10. Loss of CDKN2A Cooperates with WWTR1(TAZ)-CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma.
Seavey CN; Hallett A; Li S; Che K; Pobbati AV; Ma S; Burtscher A; Kanai R; Lamar JM; Rubin BP
Clin Cancer Res; 2023 Jul; 29(13):2480-2493. PubMed ID: 36598859
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms.
Anderson WJ; Fletcher CDM; Hornick JL
Mod Pathol; 2021 Nov; 34(11):2036-2042. PubMed ID: 34148063
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.
Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V
Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma.
Seavey CN; Pobbati AV; Rubin BP
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740643
[TBL] [Abstract][Full Text] [Related]
14. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.
Tanas MR; Ma S; Jadaan FO; Ng CK; Weigelt B; Reis-Filho JS; Rubin BP
Oncogene; 2016 Feb; 35(7):929-38. PubMed ID: 25961935
[TBL] [Abstract][Full Text] [Related]
16. TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities.
Garcia K; Gingras AC; Harvey KF; Tanas MR
Trends Cancer; 2022 Dec; 8(12):1033-1045. PubMed ID: 36096997
[TBL] [Abstract][Full Text] [Related]
17. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
Errani C; Zhang L; Sung YS; Hajdu M; Singer S; Maki RG; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2011 Aug; 50(8):644-53. PubMed ID: 21584898
[TBL] [Abstract][Full Text] [Related]
18. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study].
Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869
[No Abstract] [Full Text] [Related]
19. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract][Full Text] [Related]
20. Cytologic features of hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma.
Bourgeau M; Martinez A; Deeb KK; Reid MD; Lewis M; Point du Jour KS; Lai J; Shi Q
Diagn Cytopathol; 2021 Dec; 49(12):E447-E452. PubMed ID: 34411462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
